Cannabis Transdermal Patches Among Products to Launch in July under Atlas Thrivetm ? Powered by MÜVtm in Partnership with Verano

• Select Atlas Thrive ? Powered by MÜVtm products will sell through Shoppers Drug Mart ("Shoppers"), the largest pharmacy chain in Canada. Transdermal patches will launch in July.
• Atlas will also distribute its "Powered by MÜV" branded gels, patches, and tinctures through brick-and-mortar networks in Ontario, Alberta, British Columbia, Saskatchewan, New Brunswick, Yukon and the Northwest Territories.
• The products will be available through Ontario Cannabis Stores ("OCS") on July 13^th.
• The products will be available through Alberta Gaming, Liquor and Cannabis ("AGLC") in August.

EDMONTON, Alberta, July 12, 2021 (GLOBE NEWSWIRE) -- Atlas Biotechnologies Inc., a leading Canadian cannabis company ("Atlas" or the "Company"), today announced the launch of Atlas Thrive ? Powered by MÜVtm branded products in collaboration with leading multi-state American partner Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) ("Verano"). Powered by MÜV patches, gels and tinctures will be available exclusively through Shoppers Drug Mart's online storefront at launch. Atlas and Verano will bring Powered by MÜV products to brick-and-mortar stores across Canada with a launch date of transdermal patches at OCS on July 13 and at AGLC in August.

"As Atlas expands its distribution nationally and globally, we are excited to introduce Atlas Thrive Powered by MÜV technology in partnership with Verano. As a leader in the Canadian cannabis space, we are keen to provide effective, smokeless, and reliable health and wellness solutions to millions of Canadians," said Sheldon Croome, Atlas Founder and CEO. "We are pleased to be working closely with Verano, an industry leader in the USA, to make these new treatments available to a wider range of patients and consumers."

"We're pleased by the scope of this opportunity and the expanded footprint it provides Verano in accessing the Canadian cannabis market through the largest pharmacy chain in the country," said George Archos, Verano Co-Founder and CEO. "The prospect of introducing our award-winning MÜV products to a new market and new patients and consumers is an exciting opportunity for the company."

The patented MÜV products, including fast-acting patches, gels, and tinctures, will be available for purchase online in July for medical cannabis patients in Canada under the Atlas Thrivetm brand through Shoppers Drug Mart. Shoppers Drug Mart is the largest pharmacy chain in Canada, which is accessible to over 400,000 patients with medical cannabis prescriptions.

The Atlas Thrive MÜV THC Tincture and 1:1 Transdermal Patch will also be launching through OCS and available to the Ontario market online, and across over 800 retailers, on July 13, with Alberta following suit in August across over 600 more retailers.

About Atlas
Atlas Biotechnologies Inc. is based in Edmonton, Canada and its wholly owned subsidiaries, Atlas Growers Ltd. is federally licensed in Canada for cultivation and production of cannabis products, with a focus on health and wellness. Atlas currently produces flower, extract, topical and edible formulations with medical distribution across Canada and adult-use distribution in 7 provinces and territories, accessing over 70% of the Canadian population. Atlas operates under three brands. Atlas Growerstm is focused on medical markets, Natural Historytm on adult-use markets (www.naturalhistory.ca), and Atlas Thrivetm on the wellness market (www.atlasthrive.ca). Atlas oversees and operates multiple laboratories and cultivation facilities across Canada, providing a high level of consistency and quality in all products created under its oversight.

About Verano
Verano Holdings Inc. is a leading, vertically-integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands: Veranotm, Avexiatm, Encoretm, and MÜVtm. The company's portfolio encompasses 14 U.S. States, with active operations in 11, which includes nine production facilities comprising approximately 770,000 square feet of cultivation. Verano designs, builds, and operates dispensaries under retail brands Zen Leaftm and MÜV, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at https://verano.com/.

Forward Looking Statements
This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". The forward-looking information and forward-looking statements include, but are not limited to statements or information with respect to the Company's position in the marketplace and the accretive nature of licensing arrangements.

Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements, including, without limitation, the risk factors discussed in the Company's filings on SEDAR at www.sedar.com.

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

Contacts:

Investors:
Atlas / Christian Lopez / Investor Relations / [email protected] 
Verano / Aaron Miles / Chief Investment Officer / [email protected] 

Media:
Atlas / Jeffrey R. Gossain / COO / [email protected]
Verano / David Spreckman / VP, Marketing & Communications / [email protected]